Development of an enzyme immune assay for detecting M2 autoantibodies specific for primary biliary cirrhosis

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 2, 2003, Pages 290-294

  Jiang, Xiao Hua ^a   Fang, Xiao Yun ^a   Zhong, Ren Qian ^b   Wang, Xiu Ping ^a   Hu, Yin ^c   Kong, Xian Tao ^b  

^a No 85 Hospital of PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF ENGINEERING SCIENCE   (China)

Author keywords

Autoantibodies; Autoantigen; Biliary; Diagnosis; Immunoassay; Liver cirrhosis

Indexed keywords

2 OXOACID DEHYDROGENASE; AUTOANTIBODY; EPITOPE; HYBRID PROTEIN; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

ADULT; AFFINITY CHROMATOGRAPHY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER BIOPSY; METHODOLOGY; PRIMARY BILIARY CIRRHOSIS; PROKARYOTE; PROTEIN DOMAIN; PROTEIN PURIFICATION; RECOMBINANT PLASMID; SENSITIVITY AND SPECIFICITY;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENE EXPRESSION; HUMANS; IMMUNODOMINANT EPITOPES; LIVER CIRRHOSIS, BILIARY; PROTEIN STRUCTURE, TERTIARY;

EID: 0037867745     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Medina J, Jones EA, Garcia Monzon C, et al. Immunopathogenesis of cholestatic autoimmune liver diseases. Eur J Clin Invest 2001;31:64-71.
2. Heathcote EJ. Evidence-based therapy of primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999;11: 607-615.
3. James OEW, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390-398.
4. Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997;17:13-22.
5. Metcalf JV, Bhopal RS, Gray J, et al. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997; 26:830-836.
6. Joplin RE, Neuberger JM. Immunopathology of primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11:587-593.
7. Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet 1996; 348:1399-1402.
8. Kisand KE, Metskula K, Kisand KV, et al. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. J Gastroenterol 2001;36:248-254.
9. Koizumi H, Onozuka Y, Shibata M, et al. Positive rate of anti-mitochondrial antibody in Japanese corporate workers. Rinsho Byori 2000;48:966-970.
10. Turchany JM, Uibo R, Kivik T, et al. A study of antimitochondrial antibodies in a random population in Estonia. Am J Gastroenterol 1997;92:124-126.
11. Nakano T, Inoue K, Hirohara J, et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res 2002;22: 250-260.
12. Migliaccio C, van de Water J, Ansari AA, et al. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology 2001;33:792-801.
13. Kitami N, Komada T, Ishu H, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995;34:496-501.
14. Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol 2000;53:813-821.
15. Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34:243-248.
16. Kitami N, Ishii H, Shimizu H, et al. Immunoreactivity to M2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1994;9:7-12.
17. Jensen WA, Jois JA, Murphy P, et al. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis. Clin Chem Lab Med 2000; 38:753-758.
18. Leung PS, van de Water J, Coppel RL, et al. Molecular aspects and pathological basis of primary biliary cirrhosis. J Autoimmun 1996;9:119-128.
19. Strassburg CP, Manns MP. Autoimmune tests in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000;14:585-599.
20. Quaranta S, Shulman H, Ahmed A, et al. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol 1999;91:106-116.
21. Miyakawa H, Kikuchi K, Jong Hon K, et al. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis. J Gastroenterol 2001;36:33-38.
22. Miyakawa H, Kawaguchi N, Kikuchi K, et al. Definition of antigen specificity for antimitochondrial proteins detected by Western blotting using native mitochondrial proteins in primary biliary cirrhosis. Hepatol Res 2001;21:101-107.
23. Zhang F, Jia J, Wang B, et al. Clinical characteristics of primary biliary cirrhosis: a report of 45 cases. Zhonghua Nei Ke Za Zhi 2002;41:163-167.